Clinical trial
An Open-Label, Long-Term Safety Study to Evaluate the Safety of ThermoProfen™ for the Treatment of Mild to Moderate Pain Associated With Osteoarthritis of the Knee
NCT00532038 is registered in ClinicalTrials.gov with ZARS Pharma Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Long-Term Safety Study to Evaluate the Safety of ThermoProfen™ for the Treatment of Mild to Moderate Pain Associated With Osteoarthritis of the Knee
- Lead sponsor
- ZARS Pharma Inc.
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- September 30, 2007
- Completion date
- November 30, 2008
- Enrollment
- 179 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.